When US researchers tracked nearly 300 000 older men for five years after a screening test for prostate cancer, they found that among the 8.5% (25 208/295 645) who had a prostate specific antigen (PSA) concentration over 4 µg/L, only a third had a prostate biopsy. But most of those who …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.